SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-006595
Filing Date
2023-03-15
Accepted
2023-03-15 08:30:13
Documents
16
Period of Report
2023-03-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20230314_8k.htm   iXBRL 8-K 25974
2 EXHIBIT 99.1 ex_488786.htm EX-99.1 5986
7 image01.jpg GRAPHIC 6002
8 image02.jpg GRAPHIC 10236
  Complete submission text file 0001437749-23-006595.txt   196967

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20230315.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20230315_def.xml EX-101.DEF 11533
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20230315_lab.xml EX-101.LAB 15415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20230315_pre.xml EX-101.PRE 11689
10 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20230314_8k_htm.xml XML 2562
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 23733394
SIC: 2834 Pharmaceutical Preparations